article thumbnail

COVID-19 money could run out in January, says US government

Pharma Phorum

In a blog post , assistant secretary for preparedness and response Dawn O’Connell writes that the federal government has “always intended to transition this work to the commercial market and have been planning for that transition.”

article thumbnail

Greece slaps Novartis with €214 million bribery suit

European Pharmaceutical Review

The Greek state has filed a lawsuit against Novartis , asking for € 214 million in compensation for non-pecuniary damages* the country may have suffered due to alleged illegal payments to government officials and healthcare providers.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharma dodges a bullet, for now

World of DTC Marketing

Medicare’s innovation center may be the best avenue for lowering drug costs if provisions empowering government price negotiation don’t’ make it into a sweeping domestic spending package. Cost of healthcare in the U.S.

Pharma 197
article thumbnail

Fatique and frustration over COVID

World of DTC Marketing

In a time where healthcare is top-of-mind, this isn’t surprising. Now is a great time to huddle with your agencies to develop new creative that considers changing patient attitudes towards healthcare.

Marketing 188
article thumbnail

Value-based healthcare can help reduce costs

World of DTC Marketing

Why haven’t more employers addressed the rising costs of employee healthcare with value-based care? health insurers report billions as small providers face stress in the first quarter. This has to be upsetting to employers experiencing riding employee healthcare costs.

article thumbnail

ESG Top Trends: Healthcare ESG Impact

Pharmaceutical Technology

All aspects of environmental, social, and governance (ESG) are important, and in the healthcare industry, companies must excel across all three. Listed below are the impact of ESG on healthcare, as identified by GlobalData.

article thumbnail

Limiting the Influence of Pharmaceutical Gifts on Prescribing

Contrarian Sales Techniques

The reason for this is that gifts, even small ones, can create a sense of obligation or bias in the minds of doctors and other healthcare professionals, which can lead to them prescribing a particular medicine that may not be the best choice for the patient.

article thumbnail

Facing the Challenges and Opportunities in Digital Health Data Security

Impetus Digital

This is a guest article provided by Cybernews and does not necessarily reflect the views and values of Impetus Digital. Digital health data security is a growing concern for individuals, organizations, and government agencies.

article thumbnail

Our predictions for Pharma in 2023

Impetus Digital

Environmental, Social & Governance (ESG) in the life sciences industry. A recent McKinsey & Company report titled A vision for Medical Affairs in 2025 provides fantastic insights into the evolution of Medical Affairs.

Pharma 90
article thumbnail

Embracing digitalization in the pharmaceutical supply chain

Pharmaceutical Technology

The COVID-19 pandemic triggered significant changes to the way healthcare operates. According to Tom Lenaerts, Head of Global Process Engineering at Datwyler, this transformation will reshape the entire healthcare ecosystem.

article thumbnail

Biogen’s $900 million settlement signals scrutiny on speaker fees

Pharmaceutical Technology

Bringing an end to a 13-year deliberation on a whistleblower lawsuit, Biogen recently agreed to pay a $900 million settlement , amidst increased government alertness on pharmaceutical fraud. This prevents fraud from being committed against the government.

article thumbnail

Putting Patients First: Improving the Pharmaceutical Supply Chain

Impetus Digital

Medications and supplies must be handled with the utmost care, often needing to comply with strict temperature regulations and changing demands from patients and providers that vary depending on the country. This is a guest article written by David L.

article thumbnail

How to Integrate Direct-to-Consumer (DTC) Lab Testing into Your Telemedicine Model

Nixon Gwilt Law

Many states have laws preventing providers from using lab services to boost revenue. It ships its own kits and provides lab services without the need to use a third-party vendor. In some states, healthcare providers may not “mark up” laboratory services.

article thumbnail

Race to the finish: pharma edges closer to approval with RSV vaccines

Pharmaceutical Technology

As paediatric hospital wings are flooded with an unprecedented number of respiratory syncytial virus (RSV) cases , healthcare workers have been overwhelmed by an unusually early peak of the RSV season.

article thumbnail

Top 25 Healthcare Market Research Companies in the USA

Medico Reach

You need strategic market research to validate your credibility as a healthcare company. For this reason, you need the help of reliable healthcare market research companies. Fortunately, you can take advantage of our curated list of the top 25 healthcare market research companies.

article thumbnail

Industry Briefs November 2022

PM360

governments have been in lawsuits with the pharmacies for years, claiming they filled opioid prescriptions that should have been flagged, contributing to the drug industry’s role in an overdose crisis that has been linked to more than 500,000 deaths in the U.S.

article thumbnail

Possible cause for Paxlovid rebound uncovered

Pharmaceutical Technology

Thus, governments are simultaneously tackling issues surrounding Paxlovid rebound and aiming to increase booster uptake in their continued Covid-19 prevention efforts. In late July, the US government placed an order for 105 million doses of Pfizer’s Covid-19 vaccine as part of a $3.2

article thumbnail

Reaching Crucial Hispanic Patient Audiences

PM360

The consequences for the health industry are huge—especially considering the Hispanic population is traditionally considered a “healthcare powerhouse.” Roughly 62% prefer healthcare information resources in Spanish, while 67% say their cultural heritage influences their purchase decisions.

article thumbnail

Transforming Patient Centricity to Patient Inclusive within Medical Affairs

PM360

Traditionally, the role of Medical Affairs is to generate scientifically accurate content for disease state education or on-labeling messages to healthcare providers (HCPs). What is the value of a patient-centric approach if that approach doesn’t include the patients themselves?

article thumbnail

Accelerating HCP engagement in Singapore using customer reference data

Veeva

Veeva OpenData has one of the most accurate customer reference data sets available in the market and provides access to a wide profile of healthcare professionals and healthcare organisations in Singapore.

CRM 52
article thumbnail

Dr B raises $8m for telehealth service to deliver COVID antivirals

Pharma Phorum

The cash injection will be used to launch a telehealth service that promises to provide prescriptions and services to patients regardless of their ability to pay.

article thumbnail

Why we need to support healthcare’s vital acceleration

Pharma Phorum

With the population ageing, the need for healthcare is growing fast: between 2015 and 2050, the proportion of the world’s population over 60 years old will nearly double from 12% to 22%, according to the World Health Organization. What do I mean by vital acceleration?

article thumbnail

Philips on designing innovation and cultivating partnerships – part one

Pharma Phorum

Sachin Grover, lead of solutions vertical at Philips India, tells me about the company’s innovations during India’s COVID outbreak and how they’ve led to increased healthcare access in the region. The biggest challenge seen in India is in healthcare spending.

article thumbnail

Can genetic data be a magic bullet for drug R&D?

Pharma Phorum

Ben Hargreaves finds that the vast amount of genetic data that exists today could help provide a faster, more targeted way of developing new drug candidates. The information gathered from the project is still providing insights today, a decade later.

article thumbnail

Digital Marketing for Pharma; An Exotic Journey to Digital Future

Celeritas

With numerous channels and their presence online, healthcare providers can research the ailments and find new ways of treating them or any other diseases. Digital marketing can provide the strategies and tools to engage customers more targeted and measurable way.

article thumbnail

New HHS rule would harmonise substance abuse privacy rule, HIPAA

Pharma Phorum

Spurred by a provision of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) that passed in 2020, one effect of the rule could be to prevent situations where a person with a history of substance abuse is prescribed opioids by unknowing healthcare providers.

article thumbnail

What are the Benefits of Patient Portals?

Referral MD

One of the latest iterations of our digitization comes in the form of the patient portal, an online hub designed to keep healthcare consumers in the treatment loop. Failing to comply with these rules will result in declining government reimbursement for your practice. For Providers.

Doctors 56
article thumbnail

The pharma companies working towards supply chain sustainability

Pharmaceutical Technology

Countries and healthcare providers had to find ways to provide pharmaceutical products such as lateral flow tests (LFTs) and personal protective equipment (PPE) rapidly, accurately, and cost-effectively to contain outbreaks and protect human lives.

article thumbnail

CSL makes $4bn+ move in mRNA vaccines with Arcturus deal

Pharma Phorum

CSL Seqirus’ general manager Steve Marlow said the alliance would lead to “enhanced vaccines for influenza and multi-pathogen pandemic preparedness”, whilst also offering a potential COVID-19 booster shot to healthcare providers and governments around the world.

Pharma 52
article thumbnail

Is your system of intelligence ready for prime time? Clarify Health, Castell and Horizon executives talk AI/ML

Clarify Health

What investments are healthcare providers and payers making to advance their system of intelligence in 2022? Historically, healthcare has been reactionary, with payer and provider organizations focusing resources on addressing what has already happened.

article thumbnail

How to Choose a Good Healthcare CRM

Referral MD

The need to attract new patients through digital means is forcing healthcare into a new era of on-demand patient consumerism. The development of new platforms and technologies drive healthcare organizations to adapt in an effort to give consumers of our services exactly what they want.

CRM 52
article thumbnail

Exforge antitrust settlement caps Novartis’ year of legal disputes

Pharmaceutical Technology

In June, the Greek government filed a lawsuit against Novartis for alleged bribery and violation of the Foreign Corrupt Practices Act (FCPA). Last week, Novartis announced plans to pay $245 million to end a pay-for-delay legal battle that started in 2018.

article thumbnail

How to Utilize the Full Marketing Funnel Potential of Pharmacies

PM360

Over recent years, the pharmacy has evolved from merely the point of filling a prescription to a highly frequented healthcare destination. The pharmacy is no longer simply the last stop on a patient’s healthcare journey.

Retail 52
article thumbnail

Health Innovation Fund, Moderna’s largest shareholder, shares investment strategies

Pharma Phorum

Jack Torrance, investment specialist for Baillie Gifford’s Health Innovation Fund, tells us how the organisation ensures its investments will have the most significant positive impact on all stakeholders within the healthcare ecosystem. .

article thumbnail

Sandoz spin-off continues Novartis’ focus on innovation; $22bn purchase rumoured

Pharmaceutical Technology

GlobalData’s Contract Service Provider database shows that Novartis has 25 manufacturing sites in the US, Europe and China, including five API biologics (cell, gene, vaccine and virus) facilities in the US, France and Switzerland. stake in their consumer healthcare joint venture for $13bn.

article thumbnail

The rise of generics: market growth and global access

Pharmaceutical Technology

As healthcare providers seek to treat growing numbers of patients while facing budget constraints, generics offer a vital means to achieve this. Rising healthcare awareness, a reduction in generic drug prices, healthcare reforms and other factors have aided growth in these regions.

article thumbnail

Healthcare Price Transparency is Here. Now What?

Clarify Health

The Future of Healthcare’s Price Transparency is Here. Healthcare providers and insurers are now required to publicly disclose what they pay hospitals, doctors, and other medical providers. “I think the healthcare market is probably very similar.

article thumbnail

New technologies fuel advancements in digital health

Pharmaceutical Technology

By 2030, global spending on digital health is projected to represent 8% of all healthcare expenditure, up from 3% currently 2. Digital health is the revolution in healthcare,” says Doug Ward, the general manager of MEDIC at Mohawk College in Hamilton, Canada. “It

article thumbnail

Protection through preparation: How self-test kits became essential

Pharmaceutical Technology

Access to self-testing kits not only provides fast diagnostics results but also reduces visits to public testing centers that may exacerbate the spread of infection.

article thumbnail

Economics and risks of FDA’s Quality management maturity rating programme

European Pharmaceutical Review

1 One of the recommendations in a report by the FDA’s Drug Shortage Task Force called for the implementation of such a ratings system that would provide pharmaceutical buyers greater transparency to differentiate the quality management of drug products among manufacturers.